Cross-sectional analysis of paper mill-associated retractions in dermatology using the Retraction Watch Database, identifying 118 paper mill articles among 1,209 dermatology retractions, with data extracted on study design, topic, research integrity markers, country of origin, journal metrics, and time to retraction.
Paper mill articles represented 9.8% (118/1,209) of dermatology retractions; none appeared before 2018, with a peak of >50 in 2023. China accounted for 86% of cases, 47% focused on cutaneous oncology, 79% lacked ethics approval, none reported data availability or pre-registration, and mean time to retraction was 957 days — not significantly different from non-paper mill retractions (P = 0.53).
- Study is limited to articles explicitly labelled 'paper mill' in the Retraction Watch Database, likely underestimating true prevalence. - Cross-sectional design captures a snapshot and cannot assess causality or future trends. - Reliance on a single database may miss retractions not yet catalogued.
Clinicians and journal editors should treat missing data availability statements, absent ethics approval, and experimental designs focused on cutaneous oncology as red flags for paper mill activity. Mandating data availability statements and strengthening pre-publication screening are key steps to protect the dermatology evidence base.
Explore related topics